Learn More:
Short Courses
Preliminary Topics
Preliminary Program
  --Sunday
--Monday
--Tuesday
--Wednesday
--Thursday
--Friday
--Poster Presentations


Workshop Location
Job Opportunities

Abstract Submissions
Organizing Committee


Registration Details:
registration
Pricing Information
Cancellation/Booking Policy


Exhibitions:
Exhibition Info
IWPCPS ® -9 Exhibitors





 

I W P C P S® 9
Ninth International Workshop on Physical Characterization of Pharmaceutical Solids

Preliminary Program

Monday, June 25, 2007 AM
7:30 AM Registration
  IWPCPS – The Modern Workshop for Pharmaceutical Sciences
Angeline Zakrzewski
assainternational®

Generation of Forms
Chairperson: Dr. Sherry Morissette, Transform Pharmaceuticals; USA

Time Subject Author
 

Form Screening


S. Morissette,
Transform Pharmaceuticals; USA
 

Phase Diagrams and Form Selection


R. Chiarella,
Transform Pharmaceuticals
 

Mechanochemical Approaches for the Construction and Discovery of API Cocrystals


T. Friscic,
University of Cambridge; UK
  Polymorph Screening Using Microfluidics
P. Kenis,
University of Illinois at Urbana-Champaign; USA
 

Progesterone: A Well-Understood Polymorphic System


R. Lancaster,
University College, London; UK
 

Solvent Diversity in Polymorph Screening Experiments

M. Allesoe and J. Rantanen,
University of Copenhagen; Denmark
 
 

Monday, June 25, 2007 PM
Characterization of Forms
Chairperson: Dr. John Smoliga; , Boehringer-Ingelheim; USA
Time Subject Author
  Solid Form Characterization by Microscopical Methods
J. Smoliga,
Boehringer-Ingelheim; USA
  Interlot Variability in API: Challenges in Quantification of Amorphous Content
C. Telang,
Boehringer-Ingelheim; USA
  An Early Non-Automated Approach of Form and Salt Screening to Identify Developable Compounds
C. Donini, Merck Serono,
Switzerland
  Drug Substance Phase Characterization by Variable Temperature and Humidity X-Ray Powder Diffraction Experiments
C Field,
Boehringer-Ingelehim; USA
  Development of Risedronate: A Generic Story
J. Jirman,
Zentiva; Czech Republic
  Polymorphs/Hydrates and Human Bioavailabilit
J. Jona,
Amgen; USA
  Characterization of Formulations and Drug Products by PXRD
V. Kogan, DANNALAB; The Netherlands; D. Beckers, PANalytical; The Netherlands; J. Nicolich, PANalytical; USA

  Investigation of Hydrate/Solvate Formation over a Range of Temperatures Using Vapor Sorption Technique
D. Burnett,
SMS, USA
  Discussion Round
 

Late Monday, June 25, 2007 PM

Exhibitor Presentations

Welcoming Reception sponsored by assa international Inc. and all workshop exhibitors
Chairperson: Dr. Angeline Zakrzewski, assainternational, USA

Time Subject Author
 
 
assa® reserves the right to change the faculty and agenda to accommodate situations beyond its control. ©2005 assa Inc.; all rights reserved.

 


assa

Boehringer-Ingelheim
Pharmaceuticals

Amgen

AstraZeneca

GlaxoSmithKline

HORIBA JobinYvon

Sanofi-Aventis

TA Instruments

Transform Pharmaceuticals
(Johnson & Johnson)